New test for cancer and diabetes biomarkers 1000x more detailed
12/17/2015
A new test for detecting biomarkers for cancer and diabetes is more than 1000x more detailed and 100% faster than existing methods, new research by the University of Warwick suggests.
Personalized medicine: selective integrin ligand may facilitate specifically attacking cancer cells
12/17/2015
Integrins help cells communicate with and adapt to their environment. Also cancer cells depend on their properties to survive and spread throughout the body.
Ovarian cancer screening can reduce mortality rate
12/17/2015
A major new study shows that annual screening for ovarian cancer, particularly through blood tests and an ultrasound scan, can help reduce the rate of mortality from the disease.
Ovarian cancer screening can reduce mortality rate
12/17/2015
A major new study shows that annual screening for ovarian cancer, particularly through blood tests and an ultrasound scan, can help reduce the rate of mortality from the disease.
Most cancer cases 'caused by lifestyle, environment - not bad luck'
12/17/2015
A new study contradicts previous research by finding that 70-90% of cancers are caused by lifestyle and environmental factors such as smoking, not random DNA mutations.
New weapon in the fight against breast cancer
12/17/2015
The first clinically-relevant mouse model of human breast cancer to successfully express functional estrogen receptor positive (ER+) adenocarcinomas has been developed by researchers at Lawrence...
Scientists discover link between sleep gene and blood cancer risk
12/17/2015
A group of Argentinian researchers have conducted a study to assess the relationship between the polymorphism of the human clock gene and the risk of getting blood cancer.
Link between anemia and mild cognitive impairment
12/17/2015
In a large population-based study of randomly selected participants in Germany, researchers found that participants with anemia, defined as haemoglobin...
Studies show activity for blinatumomab in wider group of ALL patients
12/17/2015
New studies presented in Orlando, FL, provide data for use of blinatumomab in a broader group of patients with acute lymphocytic leukaemia.
New Scripps Florida compound successfully targets hard-to-treat breast cancer
12/16/2015
Findings from a new study led by scientists from the Florida campus of The Scripps Research Institute (TSRI) suggest a potent new therapeutic approach for a number of hard-to-treat breast cancers.